Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 250-253 , May 2008

Correlation between BMD and bone scintigraphy in patients with prostate cancer

  • Hakki Perk, M.D.

      Affiliations

    • Department of Urology, School of Medicine, Suleyman, Demirel University, Isparta, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-533-6267944; fax: +90-246-2371762.
    • ,
  • Mustafa Yildiz, M.D.

      Affiliations

    • Department of Nuclear Medicine, School of Medicine, Suleyman Demirel University, Isparta, Turkey
    • ,
  • Alim Kosar, M.D.

      Affiliations

    • Department of Urology, School of Medicine, Suleyman, Demirel University, Isparta, Turkey
    • ,
  • Sureyya Cerci, M.D.

      Affiliations

    • Department of Nuclear Medicine, School of Medicine, Suleyman Demirel University, Isparta, Turkey
    • ,
  • Feray Soyupek, M.D.

      Affiliations

    • Department of Physical Medicine and Rehabilitation, School of Medicine, Suleyman Demirel University, Isparta, Turkey
    • ,
  • Alper Ozorak, M.D.

      Affiliations

    • Department of Urology, School of Medicine, Suleyman, Demirel University, Isparta, Turkey
    • ,
  • Cem Dilmen, M.D.

      Affiliations

    • Department of Urology, School of Medicine, Suleyman, Demirel University, Isparta, Turkey

Received 23 January 2007 ,Revised 27 May 2007 ,Accepted 29 May 2007.

References 

  1. Landis SH, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 1999;49:8–31
  2. Soloway MS, Hardeman SW, Hickey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202
  3. Blake GM, Fogelman I. Technical principles of dual energy X-ray absorptiometry. Semin Nuc Med. 1997;27:210–228
  4. Kigami Y, Yamamoto I, Ohnishi H, et al. Relationship between skeletal uptake of 99m Tc-HMDP and bone mineral density in elderly women. Ann Nucl Med. 1998;12:15–20
  5. Franck H, Munz M. Total body and regional bone mineral densitometry (BMD) and soft tissue measurements: correlations of BMD parameter to lumbar spine and hip. Calcif Tissue Int. 2000;67:111–115
  6. Gotfredsen A, Podenphant J, Nilas L, et al. Discriminative ability of total body bone-mineral measured by dual photon absorptiometry. Scand J Clin Lab Invest. 1989;49:125–134
  7. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929–1936
  8. Tanaka H, Furukawa Y, Fukunaga K, et al. Bone mineral density for patients with bone metastasis of prostate cancer: A preliminary report. Adv Exp Med Biol. 1992;324:217–231
  9. Hauschka PV, Mavrakos AE, Iafrati MD, et al. Growth factors in bone matrix (Isolation of multiple types of affinity chromatography on heparin sepharose). J Biol Chem. 1986;261:12665–12674
  10. Gutman EB, Sproul EE, Gutman AB. Significance of increased phosphatase activity of bone at the site of osteoblastic metastases secondary to carcinoma of the prostate gland. Am J Cancer. 1998;28:485–495
  11. Lange PH, Vessella RL. Mechanisms, hypotheses, and questions regarding prostate cancer micrometastases to bone. Cancer Metast Rev. 1999;17:331–336
  12. Galasko CS. Skeletal metastases. Clin Orthop. 1986;210:18–30
  13. Tofe AJ, Francis MD, Harwey WJ. Correlation of neoplasm with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans. J Nucl Med. 1975;16:986–989
  14. Rico H, Chapado MS, Revilla M, et al. Total and regional bone mass in metastatic cancer of the prostate. Eur Urol. 1996;30:73–76
  15. Sundkvist GMG, Nilsson M, Ahlgren L, et al. Relationship between Tc-99m-MDP uptake and bone mineral density in patients with prostatic carcinoma. Nucl Med Commun. 1991;12:629–636
  16. Smith MR. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer. 2003;97:789–795
  17. Chang CH, Tsai CS, Jim YF, et al. Lumbar bone mineral density in prostate cancer patients with bone metastases. Endocr Res. 2003;29:177–182

PII: S1078-1439(07)00159-7

doi: 10.1016/j.urolonc.2007.05.027

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 250-253 , May 2008

Article Tools